{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:09:51Z","timestamp":1769587791669,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science and Technology Major Project of the Ministry of Science and Technology of China","award":["2018ZX10303502"],"award-info":[{"award-number":["2018ZX10303502"]}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2018CFC808"],"award-info":[{"award-number":["2018CFC808"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bbrc.2018.11.182","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T01:36:06Z","timestamp":1543887366000},"page":"626-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance"],"prefix":"10.1016","volume":"508","author":[{"given":"Yuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.11.182_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.bbrc.2018.11.182_bib2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2018.11.182_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/13651820410024067","article-title":"Surgical treatment of hepatocellular carcinoma","volume":"7","author":"Belghiti","year":"2005","journal-title":"HPB"},{"key":"10.1016\/j.bbrc.2018.11.182_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4254\/wjh.v7.i5.787","article-title":"Chemotherapy and target therapy for hepatocellular carcinoma: new advances and challenges","volume":"7","author":"Deng","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.bbrc.2018.11.182_bib5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2016.05.035","article-title":"Genetic profiling of hepatocellular carcinoma using next-generation sequencing","volume":"65","author":"Schulze","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2018.11.182_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000367754","article-title":"Tumor heterogeneity in hepatocellular carcinoma: facing the challenges","volume":"5","author":"Lu","year":"2016","journal-title":"Liver cancer"},{"key":"10.1016\/j.bbrc.2018.11.182_bib7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2018.04.042","article-title":"Targeting mitochondrial respiration as a therapeutic strategy for cervical cancer","volume":"499","author":"Tian","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.11.182_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2017.01.021","article-title":"Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage","volume":"483","author":"Tan","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.11.182_bib9","doi-asserted-by":"crossref","first-page":"33769","DOI":"10.18632\/oncotarget.5615","article-title":"Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration","volume":"6","author":"Xiang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.11.182_bib10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"Skrtic","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2018.11.182_bib11","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.18632\/oncotarget.3174","article-title":"Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease","volume":"6","author":"Lamb","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.11.182_bib12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0006-2952(92)90213-3","article-title":"Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80)","volume":"43","author":"Fry","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.11.182_bib13","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1074\/jbc.272.7.3961","article-title":"Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite","volume":"272","author":"Srivastava","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbrc.2018.11.182_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10863-018-9755-y","article-title":"Atovaquone enhances doxorubicin's efficacy via inhibiting mitochondrial respiration and STAT3 in aggressive thyroid cancer","volume":"50","author":"Lv","year":"2018","journal-title":"J.\u00a0Bioenerg. Biomembr."},{"issue":"2","key":"10.1016\/j.bbrc.2018.11.182_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbrc.2018.06.049","article-title":"The anti-malarial atovaquone selectively increases chemosensitivity in retinoblastoma via mitochondrial dysfunction-dependent oxidative damage and Akt\/AMPK\/mTOR inhibition","volume":"504","author":"Ke","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.11.182_bib16","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood-2015-07-660506","article-title":"Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent","volume":"128","author":"Xiang","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.11.182_bib17","first-page":"1203","article-title":"Targeting the eIF4E\/beta-catenin axis sensitizes cervical carcinoma squamous cells to chemotherapy","volume":"9","author":"Xu","year":"2017","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.bbrc.2018.11.182_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-1-59745-521-3_23","article-title":"Establishment of human cell lines lacking mitochondrial DNA","volume":"554","author":"Hashiguchi","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2018.11.182_bib19","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1592\/phco.19.13.1050.31598","article-title":"Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study","volume":"19","author":"Falloon","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbrc.2018.11.182_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/18722148113079990006","article-title":"Mitochondria in cancer stem cells: a target for therapy","volume":"7","author":"Loureiro","year":"2013","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"key":"10.1016\/j.bbrc.2018.11.182_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2018.11.182_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-5793(99)00783-8","article-title":"Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms","volume":"454","author":"Chandel","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2018.11.182_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1872-034X.2012.01113.x","article-title":"Role of sorafenib in the treatment of advanced hepatocellular carcinoma: an update","volume":"43","author":"Gauthier","year":"2013","journal-title":"Hepatol. Res. : the official journal of the Japan Society of Hepatology"},{"key":"10.1016\/j.bbrc.2018.11.182_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd3504","article-title":"Targeting cancer metabolism: a therapeutic window opens","volume":"10","author":"Vander Heiden","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2018.11.182_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ccr.2011.10.028","article-title":"Power cut: inhibiting mitochondrial translation to target leukemia","volume":"20","author":"Jaras","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2018.11.182_bib26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbrc.2017.06.115","article-title":"Inhibition of mitochondrial translation effectively sensitizes renal cell carcinoma to chemotherapy","volume":"490","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bbrc.2018.11.182_bib27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbrc.2016.02.072","article-title":"Repositioning of antibiotic levofloxacin as a mitochondrial biogenesis inhibitor to target breast cancer","volume":"471","author":"Yu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.11.182_bib28","doi-asserted-by":"crossref","first-page":"34084","DOI":"10.18632\/oncotarget.9122","article-title":"Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells","volume":"7","author":"Fiorillo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.11.182_bib29","doi-asserted-by":"crossref","first-page":"12308","DOI":"10.1038\/ncomms12308","article-title":"The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia","volume":"7","author":"Ashton","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2018.11.182_bib30","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1038\/ncomms5029","article-title":"Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action","volume":"5","author":"Birth","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2018.11.182_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2017.08.097","article-title":"Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage","volume":"492","author":"Zhu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.11.182_bib32","doi-asserted-by":"crossref","first-page":"87623","DOI":"10.18632\/oncotarget.21007","article-title":"Disrupting glucose-6-phosphate isomerase fully suppresses the \"Warburg effect\" and activates OXPHOS with minimal impact on tumor growth except in hypoxia","volume":"8","author":"de Padua","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.11.182_bib33","doi-asserted-by":"crossref","first-page":"15947","DOI":"10.1074\/jbc.RA118.004180","article-title":"Double genetic disruption of lactate dehydrogenases A and B is required to ablate the \"Warburg effect\" restricting tumor growth to oxidative metabolism","volume":"293","author":"Zdralevic","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.11.182_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4254\/wjh.v7.i7.968","article-title":"Control of oxidative stress in hepatocellular carcinoma: helpful or harmful?","volume":"7","author":"Takaki","year":"2015","journal-title":"World J. Hepatol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18326172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18326172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T06:42:23Z","timestamp":1565246543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18326172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0006291X18326172"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.182","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}